Skip to main content
HLB PHARMACEUTICAL CO., LTD. logo

HLB PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 047920 ISIN · KR7047920004 KO Manufacturing
Filings indexed 382 across all filing types
Latest filing 2026-05-22 Board/Management Inform…
Country KR South Korea
Listing KO 047920

About HLB PHARMACEUTICAL CO., LTD.

https://www.hlbpharma.co.kr/eng/

HLB PHARMACEUTICAL CO., LTD. is a biopharmaceutical company engaged in the research, development, manufacturing, and distribution of pharmaceutical products. The company specializes in the production of quasi-drugs, such as alcohol swabs for disinfecting wounds and sterilizing medical devices. Its portfolio also includes prescription medications like skeletal muscle relaxants. A key focus of its research and development activities is the discovery and advancement of new peptide-based drugs. As part of the broader HLB Group, it contributes to a diverse portfolio that spans pharmaceuticals, medical devices, and diagnostics.

Recent filings

Filing Released Lang Actions
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 88% confidence The document is a formal notice filed with the Korean Financial Supervisory Service/Korea Exchange regarding the mid-term resignation of an outside director and plans to appoint a new one at the next general meeting. It details board composition changes (number of directors before and after, reasons for resignation). This clearly falls under announcements of changes in the company’s board of directors. Hence, it is classified as "Board/Management Information" (MANG).
2026-05-22 Korean
증권신고서(지분증권)
Share Issue/Capital Change Classification · 88% confidence The document is a full securities registration statement (증권신고서) detailing the issuance of new ordinary shares, offering size, use of proceeds, investment risks, and extensive prospectus disclosures. It is not a routine earnings report or regulatory notice but a capital raising prospectus for a share issue. Therefore, it falls under Share Issue/Capital Change.
2026-05-13 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 90% confidence The document is a ‘주요사항보고서(유상증자결정)’ filed with the Korean Financial Supervisory Service/KRX, detailing the terms of a paid‐in capital increase (number of new shares, issuance price, allocation method, subscription schedule, underwriting, and related capital changes). This is not an annual or interim report, earnings release, or management presentation, but a formal announcement of a share issuance/capital change. It therefore maps directly to the “Share Issue/Capital Change” category (SHA).
2026-05-13 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 99% confidence The document is titled “분기보고서” (Quarterly Report) for the 29th fiscal period, covering January 1, 2026 to March 31, 2026. It contains full interim financial statements, business overview, capital changes, operational data, and other substantive financial details typical of an interim/quarterly report. It is not merely an announcement of publication nor a simple summary. Therefore, it matches the definition of an Interim / Quarterly Report (Code: IR). Q1 2026
2026-05-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is a “주식등의 대량보유상황보고서” detailing large shareholdings, percentages, and changes by a major shareholder and its related parties. It is a notification of significant ownership levels and contract terms, matching the definition of a Major Shareholding Notification.
2026-04-23 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 75% confidence The document is a formal disclosure filed to the Financial Services Commission and Korea Exchange regarding the grant of stock options (주식매수선택권 부여 및 정정신고). It details the number of options, grantees, exercise conditions, and corrections to a prior filing. This constitutes an announcement of a forthcoming share issuance/capital change under a stock option plan. Therefore it fits the “Share Issue/Capital Change” category (SHA).
2026-04-21 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.